Paul Wesley Lewis, MD | |
2201 Lexington Ave, Ashland, KY 41101-2843 | |
(606) 408-4000 | |
Not Available |
Full Name | Paul Wesley Lewis |
---|---|
Gender | Male |
Speciality | Interventional Radiology |
Experience | 30 Years |
Location | 2201 Lexington Ave, Ashland, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780754028 | NPI | - | NPPES |
2050248 | Medicaid | OH | |
7200076000 | Medicaid | WV | |
64961915 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 32242 (Kentucky) | Secondary |
2085R0204X | Radiology - Vascular & Interventional Radiology | 32242 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
King's Daughters' Medical Center | Ashland, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ashland Hospital Corporation | 7719882521 | 147 |
Ashland Hospital Corporation | 7719882521 | 147 |
News Archive
At an event in Washington, D.C., on Wednesday sponsored by the Hollywood, Health & Society program of the University of Southern California, panelists discussed how television storylines can raise the American public's awareness of global health issues, the Washington Examiner's blog, "Yeas & Nays," reports (Schwab/Palmeri, 3/25).
Researchers have identified factors that are associated with cycle acceleration in patients with bipolar disorder admitted to hospital for a mood episode.
New research on autism has found, in a mouse model, that drug treatment at a young age can reverse social impairments. But the same intervention was not effective at an older age.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
› Verified 3 days ago
Entity Name | Ashland Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659328250 PECOS PAC ID: 7719882521 Enrollment ID: O20031204000877 |
News Archive
At an event in Washington, D.C., on Wednesday sponsored by the Hollywood, Health & Society program of the University of Southern California, panelists discussed how television storylines can raise the American public's awareness of global health issues, the Washington Examiner's blog, "Yeas & Nays," reports (Schwab/Palmeri, 3/25).
Researchers have identified factors that are associated with cycle acceleration in patients with bipolar disorder admitted to hospital for a mood episode.
New research on autism has found, in a mouse model, that drug treatment at a young age can reverse social impairments. But the same intervention was not effective at an older age.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
› Verified 3 days ago
Entity Name | Kings Daughters Medical Specialties Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
At an event in Washington, D.C., on Wednesday sponsored by the Hollywood, Health & Society program of the University of Southern California, panelists discussed how television storylines can raise the American public's awareness of global health issues, the Washington Examiner's blog, "Yeas & Nays," reports (Schwab/Palmeri, 3/25).
Researchers have identified factors that are associated with cycle acceleration in patients with bipolar disorder admitted to hospital for a mood episode.
New research on autism has found, in a mouse model, that drug treatment at a young age can reverse social impairments. But the same intervention was not effective at an older age.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
› Verified 3 days ago
Entity Name | Ashland Radiology Associates Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285025395 PECOS PAC ID: 7315265766 Enrollment ID: O20150424002022 |
News Archive
At an event in Washington, D.C., on Wednesday sponsored by the Hollywood, Health & Society program of the University of Southern California, panelists discussed how television storylines can raise the American public's awareness of global health issues, the Washington Examiner's blog, "Yeas & Nays," reports (Schwab/Palmeri, 3/25).
Researchers have identified factors that are associated with cycle acceleration in patients with bipolar disorder admitted to hospital for a mood episode.
New research on autism has found, in a mouse model, that drug treatment at a young age can reverse social impairments. But the same intervention was not effective at an older age.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Paul Wesley Lewis, MD 2754 Solution Ctr, Chicago, IL 60677-2007 Ph: (606) 408-6200 | Paul Wesley Lewis, MD 2201 Lexington Ave, Ashland, KY 41101-2843 Ph: (606) 408-4000 |
News Archive
At an event in Washington, D.C., on Wednesday sponsored by the Hollywood, Health & Society program of the University of Southern California, panelists discussed how television storylines can raise the American public's awareness of global health issues, the Washington Examiner's blog, "Yeas & Nays," reports (Schwab/Palmeri, 3/25).
Researchers have identified factors that are associated with cycle acceleration in patients with bipolar disorder admitted to hospital for a mood episode.
New research on autism has found, in a mouse model, that drug treatment at a young age can reverse social impairments. But the same intervention was not effective at an older age.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
› Verified 3 days ago
Eugene R Degiorgio, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 Saint Christopher Dr, Ashland, KY 41101 Phone: 606-833-2273 | |
Garrick Todd Sherman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 Fax: 606-408-6212 | |
Anshu K Jain, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 122 Saint Christopher Dr, Ashland, KY 41101 Phone: 606-836-0202 | |
Mayola W Boykin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 | |
Robert Ray Penkava, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 | |
Dr. Dhirenkumar Desai, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 | |
Dr. Pho M. Nguyen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 520, Ashland, KY 41101 Phone: 606-393-0190 Fax: 606-393-5169 |